PMC:7195088 / 42616-42749 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1208","span":{"begin":83,"end":96},"obj":"Chemical"},{"id":"1210","span":{"begin":29,"end":62},"obj":"Disease"}],"attributes":[{"id":"A1208","pred":"tao:has_database_id","subj":"1208","obj":"MESH:D014280"},{"id":"A1210","pred":"tao:has_database_id","subj":"1210","obj":"MESH:C564286"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"rug Adverse events\nLopinavir/ritonavir • Hypercholesterolaemia and increased serum triglycerides (3–39%)\n• Increased γ-glutamyl trans"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T65","span":{"begin":77,"end":82},"obj":"Body_part"}],"attributes":[{"id":"A65","pred":"fma_id","subj":"T65","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"rug Adverse events\nLopinavir/ritonavir • Hypercholesterolaemia and increased serum triglycerides (3–39%)\n• Increased γ-glutamyl trans"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T36","span":{"begin":77,"end":82},"obj":"Body_part"}],"attributes":[{"id":"A36","pred":"uberon_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"rug Adverse events\nLopinavir/ritonavir • Hypercholesterolaemia and increased serum triglycerides (3–39%)\n• Increased γ-glutamyl trans"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T45","span":{"begin":67,"end":96},"obj":"Phenotype"}],"attributes":[{"id":"A45","pred":"hp_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/HP_0002155"}],"text":"rug Adverse events\nLopinavir/ritonavir • Hypercholesterolaemia and increased serum triglycerides (3–39%)\n• Increased γ-glutamyl trans"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T528","span":{"begin":19,"end":28},"obj":"Chemical"},{"id":"T529","span":{"begin":29,"end":38},"obj":"Chemical"},{"id":"T530","span":{"begin":83,"end":96},"obj":"Chemical"},{"id":"T531","span":{"begin":119,"end":127},"obj":"Chemical"}],"attributes":[{"id":"A528","pred":"chebi_id","subj":"T528","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A529","pred":"chebi_id","subj":"T529","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A530","pred":"chebi_id","subj":"T530","obj":"http://purl.obolibrary.org/obo/CHEBI_17855"},{"id":"A531","pred":"chebi_id","subj":"T531","obj":"http://purl.obolibrary.org/obo/CHEBI_32483"}],"text":"rug Adverse events\nLopinavir/ritonavir • Hypercholesterolaemia and increased serum triglycerides (3–39%)\n• Increased γ-glutamyl trans"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T314","span":{"begin":19,"end":104},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"rug Adverse events\nLopinavir/ritonavir • Hypercholesterolaemia and increased serum triglycerides (3–39%)\n• Increased γ-glutamyl trans"}